Navigation Links
Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
Date:7/7/2010

s

Certain statements set forth above may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to: (i) our plans to develop and commercialize our product candidates, including our Neo-Urinary Conduit; and (ii) our ongoing and planned preclinical studies and clinical trials. Although the company believes that such statements are based on reasonable assumptions within the bounds of its knowledge of its business and operations, the forward-looking statements are neither promises nor guarantees and the company's business is subject to significant risk and uncertainties, and there can be no assurance that its actual results will not differ materially from its expectations. These risks and uncertainties include, among others: (i) we may have difficulty enrolling patients in our clinical trials, including our Phase I clinical trial for our Neo-Urinary Conduit; (ii) patients enrolled in our clinical trials may experience adverse events related to our product candidates, which could delay our clinical trials or cause us to terminate the development of a product candidate; and (iii) we may be unable to progress our product candidates that are undergoing preclinical testing into clinical trials. For further information with respect to factors that could cause the company's actual results to differ materially from expectations, reference is made to the reports the company filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. The forward-looking statements made in this release are made only as of the date hereof and the company disclaims any intention or responsibility for updating predictions or expectations contained in this release.


'/>"/>
SOURCE Tengion Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
2. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
3. Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM)
4. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. West Pharmaceutical Services, Inc. Appoints New Director
7. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
8. Curemark Appoints Preeminent Pediatrics Gastroenterologist
9. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
10. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
11. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Utah , March 2, 2015  BC ... Imaging Solutions, has acquired Eclipse Systems, a Nuclear ... service solutions. As part of their ongoing vision ... at an affordable rate, BC Technical continues to ... allows BC Technical to add valuable resources and ...
(Date:3/2/2015)... GERMANTOWN, Md., March 2, 2015  Intrexon Corporation ... synthetic biology, today announced its fourth quarter and ... Business Highlights and Recent Developments: , Acquired ... a new frontier in cellular therapeutics and other ... molecular engineering of food-grade microbes ( Lactococcus lactis ...
(Date:3/2/2015)... March 2, 2015 When someone gets sick, their ... a primary care physician or an urgent care facility ... the healthcare provided by doctors and medical professionals comes ... it,s not ideal in every circumstance. Though it may ... where occupants have higher chances of contracting illnesses. Also, ...
Breaking Medicine Technology:BC Technical Acquires Eclipse Systems 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 3Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 4Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 6Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 7Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 8Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 9Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 10Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 11Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 12Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 13Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 14Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 15Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 16Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 17Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 18Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 19Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 20Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 21Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 22Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 23Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 24House Call Medicine Helps Patients Receive Treatment While Avoiding the Hassles and Potential Risks of an Urgent Care Facility 2
... VIEW, Calif., Dec. 3, 2010 VIVUS, Inc. ... senior management will present an overview of the ... of December.The conference presentation schedule is as follows:Canaccord ... at 12:30 p.m. PTNikko Hotel, San Francisco, CAPresenter: ...
... MOUNTAIN VIEW, Calif., Dec. 3, 2010 Omnicell, ... provider of medication management solutions to acute healthcare facilities, ... American Society for Health-System Pharmacists (ASHP) Midyear Clinical Meeting ...  New solutions being unveiled or previewed include the new ...
Cached Medicine Technology:Omnicell to Showcase Latest Product Innovations at ASHP 2Omnicell to Showcase Latest Product Innovations at ASHP 3Omnicell to Showcase Latest Product Innovations at ASHP 4Omnicell to Showcase Latest Product Innovations at ASHP 5
(Date:3/2/2015)... Ticket Down is a reputable source for ... This popular site has reduced all ticket prices and ... added savings. , Parrotheads in the Los Angeles area ... at the Hollywood Bowl for the first time since ... 22nd and it will be in conjunction with Buffett's ...
(Date:3/2/2015)... March 02, 2015 Doctors in Novara, ... a better predictor of outcomes for people with mesothelioma ... details of the new study on the Surviving ... the University of Eastern Piedmont followed the cases of ... treatment for excess lung fluid. , “Persistent lung ...
(Date:3/2/2015)... MN (PRWEB) March 02, 2015 ... temperature calibration for Secondary Standard Platinum Resistance ... in 5 business days or less . . ... NVLAP ® Accredited (Lab Code 200706-0), ISO ... traceability. Temperature range is -196°C to 500°C, ...
(Date:3/2/2015)... 2015 The minimally invasive surgical ... CAGR of 6.1% to reach $14,133.0 million by ... Factors such as advantages of minimally invasive surgeries ... to minimally invasive surgeries and increasing number of ... the global minimally invasive surgical instruments market. , ...
(Date:3/2/2015)... Hawaii (PRWEB) March 02, 2015 Four Seasons ... is celebrating its 25th anniversary this year, having officially opened ... milestone, the luxury resort is honoring over 70 employees who ... resort -- from amongst the approximately 400 original employees. ... the Resort’s Oceanfront Lawn. , This Four Seasons ...
Breaking Medicine News(10 mins):Health News:Cheap Jimmy Buffett Tickets Hollywood Bowl: Ticket Down Slashes Prices on Jimmy Buffett Tickets at the Hollywood Bowl in Los Angeles/Hollywood, CA 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2
... ... Marriott, Neiman Marcus, Dell, and Home Depot. Is he right or wrong? ... (PRWEB) April 7, ... South Carolina’s Criminal Justice Academy’s annual Police Chiefs’ workshop this morning., , ,Chief Lance ...
... failed, trial results show , WEDNESDAY, April 7 (HealthDay ... second-round treatment for hepatitis cures about half the people ... research shows. , "This is the first large study ... said Dr. John G. McHutchison, associate director of the ...
... TriLipo ... body. Clinically proven, the maximus system powered by TriLipo, is a new medical system ... skin tightening. , ... Tel Aviv, Israel (PRWEB) April 7, 2010 - Pollogen Ltd , a ...
... Behavior may increase need for protection from sexually transmitted ... in nonromantic sexual relationships today are likely to have ... promote the spread of sexually transmitted diseases, they note. ... toward nonromantic sexual partnerships -- people becoming sexually involved ...
... An elderly woman suspected of having a stroke arrives confused ... she is able to provide to access the critical medical ... that,s the promise of health information technology. To move ... University of Texas Health Science Center at Houston (UTHealth) have ...
... prediction that due to the obesity epidemic Baby Boomers may ... University of Michigan Health System on obesity trends shows Americans ... longer periods over their lifetime. As a result, ... expectancy may be worse than previously thought. The findings will ...
Cached Medicine News:Health News:Are the Cops Now Competing With Disney? 2Health News:New Drug Shows Promise for Curing Hepatitis C 2Health News:New Drug Shows Promise for Curing Hepatitis C 3Health News:Pollogen Launches the Maximus, Advanced Solution for Fat Reduction and Body Shaping based on Innovative TriLipo Technology 2Health News:Pollogen Launches the Maximus, Advanced Solution for Fat Reduction and Body Shaping based on Innovative TriLipo Technology 3Health News:Casual Sex Increasing in U.S. 2Health News:UTHealth receives $15 million for health information technology research 2Health News:UTHealth receives $15 million for health information technology research 3Health News:UTHealth receives $15 million for health information technology research 4Health News:Getting heavier, younger: U-M study shows generational shift in obesity 2
... Urinalysis WorkCell System - A Single ... per hour, with true load-and-go productivity ... Clinitek Atlas and UF-100 for complete ... systems working together deliver utmost reliability. ...
... one of the 3 major naturally occurring ... In terms of estrogenic activity, estriol is ... is produced almost exclusively during pregnancy, and ... normal human fetus. During pregnancy, the production ...
... of the three major naturally-occurring estrogens. Other ... is produced primarily from androstenedione originating from ... In premenopausal adult women, more than 50% ... In prepubertal children, men and postmenopausal women, ...
... Estrone Enzyme Immunosorbent Assay (EIA) Kit ... of Estrone in serum. The procedure ... immunoassay where there is competition between ... antigen for a fixed number of ...
Medicine Products: